GE increases cell culture media production capacity by tenfold

Chalfont St Giles, UK, Pasching, Austria & Logan, Utah, US– 16 May 2018 — GE Healthcare Life Sciences is increasing the annual production capacity of powdered cell culture media by tenfold in its facility in Pasching, Austria. The newly built manufacturing suite will help to strengthen product supply for biopharmaceutical companies in Europe. GE is... Read more

Greiner Bio-One acquires 3D Cell Culture Technology assets from Nano3D Biosciences, Inc.

08. May 2018 Greiner Bio-One Magnetic 3D Cell Culture Products Greiner Bio-One North America, Inc. has acquired 3D Cell Culture Technology previously owned by Nano 3D Biosciences, Inc. As an international distributor of these products since 2016, Greiner Bio-One has now taken the initiative to become a premier provider of this technology worldwide. Magnetic 3D... Read more

MilliporeSigma Advances Cell Analysis with New Benchtop Flow Cytometer with Camera Detection

News Release April 27, 2018 Your Contact: Karen Tiano +1 978 495 0093 MilliporeSigma Advances Cell Analysis with New Benchtop Flow Cytometer with Camera Detection Highly sensitive optical system based on patented technology unique to MilliporeSigma’s Amnis® flow cytometers Configurable, 7-laser capacity to meet researchers’ evolving needs Laser upgrades quickly performed in lab with no... Read more

10x Genomics Completes $50 Million Series D Financing and $75M Debt Facility

PLEASANTON, CA.—April 26, 2018—10x Genomics, a company focused on accelerating genomic discovery, today announced that it had raised $125 million in funding. The funding included a $50 million Series D financing. It was led by Meritech Capital Partners and included new investor Wells Fargo Strategic Capital along with current investors Paladin Capital, Fidelity and the... Read more

Ready-to-use, synthetic surface cultureware for human induced pluripotent stem cells (hiPSCs) coming to market

Hamburg, April 2018 The major aim during the multi-passage cultivation of pluripotent stem cells (PSCs) is to preserve their differentiation and growth potential. Here, the proper selection of a defined culture system that consists of a growth surface and culture medium is crucial. The commonly used biological coating materials for PSC expansion are based on... Read more

BD Launches BD FACSymphony™ S6 High Parameter Cell Sorter to Enable Sorting of Rare Cell Types

FRANKLIN LAKES, N.J., April 26, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSymphony™ S6 cell sorter, which will be on display at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague. The new platform... Read more

RareCyte introduces the CyteFinder® HT instrument at AACR for high throughput slide-based imaging optimized for single cell Liquid Biopsy

SEATTLE, April 16, 2018 /PRNewswire/ — RareCyte, Inc., a global rare cell detection and liquid biopsy company, announces its newest product, CyteFinder HT in conjunction with the American Association for Cancer Research (AACR) Annual Meeting in Chicago April 15 through 18. CyteFinder HT, RareCyte’s newest member of the CyteFinder family, enables high-speed whole slide imaging with up to six channels... Read more

Magnetic 3D Cell Culture Products from Greiner Bio-One Validated for Use as an Ex Vivo Pancreatic Tumor Model for High Throughput Cancer Drug Screening

Greiner Bio-One North America, Inc. is announcing the publication in SLAS Discovery of an article titled “Advanced Development of Primary Pancreatic Organoid Tumor Models for High Throughput Phenotypic Drug Screening”. Authored by The Scripps Research Institute in Florida, in collaboration with Cold Spring Harbor Laboratory, Greiner Bio-One, Nano3D Biosciences, Inc., University of Texas Health Science... Read more

Fluidigm Introduces High-Parameter Maxpar Immune Monitoring Panel for Translational and Clinical Research

PDF Version Providing the industry’s first commercially available high-parameter immune monitoring solution for deep profiling of PBMC, Fluidigm brings proven mass cytometry together with innovative third-party data analysis SOUTH SAN FRANCISCO, Calif., April 13, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Maxpar® Human Immune Monitoring Panel Kit for comprehensive immune cell profiling in... Read more